We scale peptide brands on Meta.
Every peptide brand hits the same wall: the ads get rejected, the account gets flagged, and growth resets to a burner. Pepscale writes the ads, builds the pages, and launches them with a method built for this one category, so the account stays open and the winners keep running. One operator. Peptides only. Limited seats.
Peptide brands. Real numbers.
Every screenshot below is a peptide brand account we run. Straight from Ads Manager, names hidden. Tap any screenshot to enlarge it.
Every peptide brand hits the same three walls.
Tap any card to read what actually happens.
The full story
Meta does not ban peptide brands because it hates peptides. It bans them because the ads, the pages and the account behaviour look exactly like the pattern its review is trained to catch. Supplement claims on a peptide product. A landing page that says one thing and a checkout that says another. A fresh account that spends hard on day one.
The usual response is a new account. Then another. Each one is younger, spends faster and looks more like the pattern than the last, so it dies sooner. Brands end up running their whole growth engine on borrowed time.
The Protocol is the opposite of that. One account, set up and warmed to hold. Ads written to pass review before they are written to sell. A launch cadence that grows spend without ever tripping the pattern. When something is flagged, it gets handled inside the same account, not by starting over.
The result is boring in the best way: ads that stay live for months, on an account that stays open, so the winners actually get to compound.
The full story
Peptide buyers are not supplement buyers. They read, they compare, they know the names. The ad that wins is the one that respects that: education first, proof second, offer last.
That same structure is what gets through review. An ad that informs reads like content. An ad that promises reads like a violation. We write for the buyer and the reviewer at once, because in this category they are the same gate.
Every static, every video, every page is built for peptides from scratch. Nothing is recycled from a skincare playbook.
The full story
Generic agencies treat a peptide brand like any other DTC account: broad targeting, aggressive claims, scale on day three. It works for a week, then the account is gone and the invoice still arrives.
Freelancers who "know the workaround" usually mean burner accounts. That is not a method, it is a countdown.
Pepscale does one thing. The method stays sharp because it only ever has to work for one category, and every lesson from one account goes into the next.
The Pepscale Protocol.
A launch method built for one category. The creative is written to pass review and still sell. The account is built and warmed to hold. Scaling follows a cadence that never trips the pattern Meta flags. Ads that stay live, on accounts that stay open.
Every hook, claim and page written for peptide buyers, and for the reviewer reading it.
One account, set up and warmed the right way. No burners, no resets.
Budgets, structure and timing that grow spend without tripping the pattern.
When an ad works it runs for months, not days. That is where the profit is.
One operator. Every account. Every day.
Peptide brands get the leftovers: generic agencies who have never run the category, or freelancers who burn through accounts. There is almost nobody who has done this properly, end to end. That is the gap Pepscale fills.
Every peptide brand we talk to has the same story: the ads worked, then the account died. That is the problem the Protocol exists for.
Laurence Haslauer
Founder of Pepscale. Built and launched DTC brands in skincare, pet care and personal care, writing the ads, building the pages and buying the media himself. Peptides are the category where that full stack matters most, because one weak link costs the whole account.
The Pepscale Protocol
Creative written for the buyer and the reviewer at once. An account built and warmed to hold. A scaling cadence that grows spend without tripping review. Remove any one layer and the account dies. Run all three and it stays open.
The deal is simple.
- Full service: research, ads, pages, account setup, launch, daily optimization
- One number, stated plainly on the call. No long contracts
- The founder in your account, every day. No juniors
- Every ad and every page approved by you before it goes live
- Leave whenever it stops making sense
Research, account setup, first ads
Pages, pixel and tracking
Launch, then scale by cadence
Quick answers.
How much does it cost?
One number, stated on the call and built around your spend. No long contracts. You can hold it against any quote you have ever received, and against what a dead account costs you every month.
We ran Meta before and the account got banned.
Almost every peptide brand we speak to has. The account did not die because Meta hates peptides. It died because the ads, the page or the launch pattern tripped review, and the usual fix, a new account, made it worse. The Protocol is built to avoid exactly that.
Can you guarantee we never get flagged?
No, and anyone who says yes is selling you a burner. What we can say: the method is built from the ground up for this category, every ad is written to pass review before it is written to sell, and when something is flagged we handle it inside the same account instead of starting over.
Do you only work with peptide brands?
Yes. One category, so the method stays sharp and every lesson from one account goes into the next. If you sell something else, we are the wrong fit and will say so.
Who makes the creatives?
We do. Statics, video, and the pages behind them, written and built for peptide buyers from scratch. You approve every angle and every page before anything goes live. Your brand, your veto.
Do you need access to our ad account?
We work inside your Business Manager, in an account we set up or repair together. It stays yours, with your pixel and your data. You can see everything we do, every day.
Why limited seats?
Because it is one operator doing the work, on every account, daily. That attention does not scale past a handful of brands, and we would rather cap the roster than hand you to a junior.
It is not a pitch. We look at your product, your margins and your account history, and tell you whether the Protocol fits. If it does not, we will be the ones to say it.
Ads that stay live, on accounts that stay open.